# OrisDX

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/orisdx

- Industry: Biotechnology
- Headquarters: Chicago, US
- Website: www.orisdx.com
- Total disclosed funding: $4M
- Latest round: Seed (Jun 10, 2025)
- Investors on record: 4

## About

OrisDX Inc. is a US-based company dedicated to enhancing healthcare through advanced diagnostic platforms and software services, providing innovative tools to improve clinical decision-making and operational workflows.Founded in 2022 and headquartered in Chicago, US, OrisDX Inc. focuses on developing diagnostic solutions for the healthcare sector. The company has completed one deal, raising USD 4.000 mn in its Seed funding round on June 10, 2025, with investors including CareQuest Innovation Partners, Inc., MFV Partners, Revere Partners, and UCM Ventures. The founder's history is not publicly available.OrisDX specializes in delivering tailored solutions for the healthcare industry, particularly through its advanced diagnostic platforms and software services. Its flagship products include a suite of diagnostic tools designed to enhance clinical decision-making and streamline workflow processes. These solutions allow healthcare professionals to analyze patient data effectively, ensuring accurate diagnoses and timely treatment interventions. OrisDX's clientele includes hospitals, outpatient clinics, and laboratory service providers in North America and Europe, focusing on improving patient outcomes by facilitating reliable diagnostic processes.OrisDX generates revenue through subscription-based services and direct sales of diagnostic tools. The business model includes partnerships with healthcare institutions, enabling the integration of OrisDX solutions at negotiated rates. Clients typically sign annual subscription plans for software updates, training, and technical support, with pricing designed for various scales of operation, ensuring both a consistent revenue stream and fostering customer loyalty through ongoing engagement.In June 2025, OrisDX Inc. raised USD 4.000 mn in Seed funding, which will be utilized to enhance its diagnostic platform. The company plans to expand its product offerings and is actively exploring entry into new geographic markets. Specific countries and regions targeted for expansion are not publicly disclosed at this time.

## Funding rounds

- Seed, Jun 10, 2025, $4M — MFV Partners, Revere Partners, CareQuest Innovation Partners, Inc., UCM Ventures

## Investors

- MFV Partners (https://capitalatlas.ai/funds/mfv-partners) — Seed
- Revere Partners (https://capitalatlas.ai/funds/revere-partners) — Seed
- CareQuest Innovation Partners, Inc. — Seed
- UCM Ventures — Seed